Hi, I’m Stuart Talley with Kershaw|Talley. Bill Kershaw and I are the partners responsible for providing updates on the Stryker Rejuvenate and Stryker ABG II litigation case.
I am providing an update concerning recent developments about cobalt and chromium toxicity. The developments discuss whether or not high doses of the metals can cause or increase the risk of cancer. Recently, there was a scientific study issued from Finland. In the paper, the scientists examined individuals with metal on metal hips who had high cobalt and chromium levels. They compared these individuals with others implanted with metal-on-plastic hips. This specific research is ongoing since people continue to experience issues with metal on metal hips, and the release of cobalt and chromium ions from their hip joint.
So far, there are no studies suggesting a correlation between elevated levels of cobalt and chromium in the blood and an increased risk for cancer. However, this does not negate the fact that there may be a link; there is just no current evidence to substantiate a link.
In the Finland study, doctors analyzed 10,000 patients with metal on metal hips and compared them to 18,000 patients with conventional metal-on-plastic hips. They found no statistical increase in the rate of cancer between the two groups from their previous study in 2012. Europe is making a conscious effort to monitor patients with metal on metal hips and metal-on-plastic hips in order to assess the risk of cancer. The link between metal on metal hips and an increased risk for cancer may become apparent in the future.
We represent hundreds of individuals with various metal on metal hips including Stryker Rejuvenate and Stryker ABG II. If you have any questions or concerns, please call us, toll free, at 888-635-3970 or visit our website www.defectivehipsettlementcenter.com and fill out the contact form for a free evaluation.